Who makes hDNAgr Therapy?

hDNAgr Therapy is developed by S.LAB (SOLOWAYS).

Last reviewed 2026-04-19 · How we verify

hDNAgr Therapy

S.LAB (SOLOWAYS) · Phase 1 active Biologic

At a glance

Generic name	hDNAgr Therapy
Sponsor	S.LAB (SOLOWAYS)
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of the Safety and Efficacy of Natural Genome Reconstruction Technology of Hematopoietic Stem Cells in Adult Patients (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

hDNAgr Therapy CI brief — competitive landscape report
hDNAgr Therapy updates RSS · CI watch RSS
S.LAB (SOLOWAYS) portfolio CI